Chemotherapy followed by irreversible electroporation in patients with unresectable locally advanced pancreatic cancer

Flak, Rasmus Virenfeldt (PI (principal investigator))
Thorlacius-Ussing, Ole (Supervisor)
Stender, Mogens (PI (principal investigator))
Dikinis, Sarunas (PI (principal investigator))
Falkmer, Ursula Gerda Inge (PI (principal investigator))
Fisker, Rune Vincents (PI (principal investigator))
Jensen, Thomas Mandøe (PI (principal investigator))
Naujokaite, Gintare (PI (principal investigator))
Mortensen, Peter Brøndum (PI (principal investigator))
Petersen, Lars Michael Jelstrup (PI (principal investigator))
Yilmaz, Mette Karen (PI (principal investigator))
Andersen, Kasper Lenni (PI (principal investigator))

Beskrivelse

A phase II trial of irreversible electroporation for the treatment of unresectable locally advanced pancreatic cancer.

Akronym	CHEMOFIRE-2
Status	Afsluttet
Effektiv start/slut dato	01/05/2019 → 30/04/2024

ISEBTT early career investigator award for research of exceptional quality
Flak, R. V. (Modtager), 6 sep. 2019
Pris: Konferencepriser

Fil